RxSight, Inc. Common Stock (RXST) — Analysis Summary
RxSight, Inc. Common Stock (RXST) has a market cap of $220.64M with year-over-year revenue growth of -3.9%. Net margin stands at -29.0%. The stock trades at a P/E ratio of -4.7.
Key Takeaways
- Revenue changed -3.9% year-over-year
- Net margin of -29.0%
- P/E ratio of -4.7
Compared to other companies in the OPHTHALMIC GOODS sector, RXST posted revenue growth of -3.9% and trades at a P/E of -4.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.